Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Celgene Corp /de/
Relationship:  
City:   Summit
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   9    
Direct Shares   56,020,938    

Indirect Shares

   6,630,042      
Direct Value   $1,691,885,599    

Indirect Value

   $287,034,994      
Total Shares   62,650,980      
Total Value   $1,978,920,593      


Casi Pharmaceuticals Inc $38,712,500 Epizyme, Inc. $5,401,721 Acceleron Pharma Inc $1,219,912,444 Alliqua BioMedical Inc $19,726,764 Globeimmune Inc $0 Crispr Therapeutics Ag $260,170,274 Jounce Therapeutics Inc $6,498,150 Agios Pharmaceuticals Inc $135,007,769 Sutro Biopharma Inc $6,455,977 Casi Pharmaceuticals Inc $38,712,500 Epizyme, Inc. $5,401,721 Acceleron Pharma Inc $1,219,912,444 Alliqua BioMedical Inc $19,726,764 Globeimmune Inc $0 Crispr Therapeutics Ag $260,170,274 Jounce Therapeutics Inc $6,498,150 Agios Pharmaceuticals Inc $135,007,769 Sutro Biopharma Inc $6,455,977
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Casi Pharmaceuticals Inc CASI 10% Owner 2005-03-31 23,750,000 2005-03-31 0    Premium*  
            Epizyme, Inc. EPZM 10% Owner 2014-02-10 3,674,640 2013-06-05 0    Premium*  
            Acceleron Pharma Inc XLRN 2019-01-18 6,824,685 2013-09-24 0    Premium*  
            Alliqua BioMedical Inc ALQA 10% Owner 2017-04-11 7,342,377 0    Premium*  
            Globeimmune Inc GBIM 10% Owner 2014-07-08 400,670 2014-07-08 600,670    Premium*  
            Crispr Therapeutics Ag CRSP 10% Owner 2016-10-24 4,834,980 2018-11-21 4,173,019    Premium*  
            Jounce Therapeutics Inc JNCE 10% Owner 2017-02-01 3,456,463 2017-02-01 0    Premium*  
            Agios Pharmaceuticals Inc AGIO 10% Owner 2017-04-24 4,010,926 2017-04-24 1,856,353    Premium*  
            Sutro Biopharma Inc STRO 2018-10-01 1,726,197 2018-10-01 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
XLRN Acceleron Pharma Inc   –       –       •   2019-01-18 4 B $43.00 $30,366,858 D/D 706,206 6,824,685 0.01 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2018-11-21 4 S $19.25 $1,540,000 I/I (80,000) 4,173,019 0 -
STRO Sutro Biopharma Inc   –       –       •   2018-10-01 4 A $0.00 $0 D/D 1,726,197 1,726,197 0 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2017-12-04 4 S $19.47 $593,543 I/I (30,485) 3,722,534 0 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2017-12-01 4 S $19.10 $1,680,628 I/I (87,991) 3,753,019 0 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2017-11-30 4 S $19.04 $241,161 I/I (12,666) 3,841,010 0 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2017-11-29 4 S $19.25 $82,063 I/I (4,263) 3,853,676 0 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2017-11-28 4 S $19.22 $97,638 I/I (5,080) 3,857,939 0 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2017-11-27 4 S $19.75 $552,803 I/I (27,990) 3,863,019 0 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2017-11-24 4 S $20.00 $520,200 I/I (26,010) 3,891,009 0 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2017-11-22 4 S $19.76 $5,058,560 I/I (256,000) 3,917,019 0 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2017-11-20 4 S $19.02 $3,018,816 I/I (158,718) 4,253,019 0 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2017-11-17 4 S $18.44 $945,640 I/I (51,282) 4,411,737 0 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2017-11-16 4 S $18.39 $1,930,950 I/I (105,000) 4,463,019 0 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2017-11-15 4 S $17.67 $265,050 I/I (15,000) 4,568,019 0 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2017-11-14 4 S $17.19 $256,251 I/I (14,907) 4,583,019 0 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2017-11-13 4 S $17.76 $1,156,052 I/I (65,093) 4,597,926 0 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2017-11-10 4 S $17.28 $172,800 I/I (10,000) 4,663,019 0 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2017-11-09 4 S $17.08 $341,600 I/I (20,000) 4,673,019 0 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2017-11-08 4 S $18.06 $304,763 I/I (16,875) 4,693,019 0 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2017-11-07 4 S $18.54 $426,420 I/I (23,000) 4,709,894 0 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2017-11-06 4 S $18.89 $1,498,487 I/I (79,327) 4,732,894 0 -
CRSP Crispr Therapeutics Ag 10% Owner   –       –       •   2017-11-03 4 S $19.10 $434,697 I/I (22,759) 4,812,221 0 -
XLRN Acceleron Pharma Inc 10% Owner   –       –       •   2017-09-25 4 B $37.00 $27,586,904 D/D 745,592 6,118,479 2.45 -
AGIO Agios Pharmaceuticals Inc 10% Owner   –       –       •   2017-04-24 4 B $49.50 $30,916,463 I/I 624,575 1,856,353 1.5 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us